+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chronic Disease Management Market by Disease Type, Product Type, Service Type, End User, Distribution Channel, Care Setting - Global Forecast to 2030- Product Image
Chronic Disease Management Market by Disease Type, Product Type, Service Type, End User, Distribution Channel, Care Setting - Global Forecast to 2030- Product Image
Sale

Chronic Disease Management Market by Disease Type, Product Type, Service Type, End User, Distribution Channel, Care Setting - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010859
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Chronic Disease Management Market grew from USD 10.12 billion in 2024 to USD 10.85 billion in 2025. It is expected to continue growing at a CAGR of 6.89%, reaching USD 15.10 billion by 2030.

The Rising Imperative for Comprehensive Chronic Disease Management

Chronic diseases represent a mounting global challenge, exerting immense pressure on health systems, patients, and payers alike. As prevalence continues to rise, stakeholders require robust frameworks for prevention, monitoring, and treatment to mitigate long-term costs and clinical burdens. This executive summary offers decision-makers a clear lens into the multifaceted landscape of chronic disease management, spotlighting the innovations and strategies poised to drive superior outcomes.

In a context defined by aging populations and shifting lifestyle risk factors, the integration of digital health solutions, advanced therapeutics, and personalized care pathways has never been more critical. This introduction frames the imperative for comprehensive, patient-centric management approaches that align clinical efficacy with economic sustainability. By understanding current obstacles and emerging opportunities, executives can chart a course toward more resilient health care models.

Converging Forces Reshaping Chronic Care Delivery

The chronic disease management landscape is undergoing a profound transformation fueled by several converging forces. Technological advances in remote monitoring and analytics platforms are redefining traditional care pathways, enabling continuous patient engagement beyond hospital walls. Simultaneously, value-based reimbursement models are incentivizing providers to demonstrate tangible improvements in patient outcomes and cost efficiency.

Policy reforms are further accelerating this shift, as regulatory agencies emphasize digital therapeutics and telehealth solutions to expand access and optimize resource allocation. Meanwhile, patient expectations are evolving toward on-demand, personalized interventions that adapt to individual risk profiles and lifestyle patterns. This section explores how these dynamics intersect to reshape clinical workflows, foster cross-sector partnerships, and drive a new era of data-driven chronic disease care.

United States Tariffs in 2025 and Their Ripple Effects

Recent tariff adjustments announced in the United States for 2025 have introduced new complexities into global supply chains for medical devices, pharmaceuticals, and health care software. Increased duties on key components such as implantable defibrillators and continuous glucose monitors have necessitated strategic sourcing reviews and cost realignment across multiple stakeholders. Providers and manufacturers are evaluating the balance between onshore production and diversified import channels to mitigate pricing pressures and maintain product availability.

These tariff measures also carry downstream implications for therapeutic access and patient affordability. Payers are recalibrating reimbursement frameworks to account for higher equipment acquisition costs, while emerging players are exploring localized manufacturing partnerships to sustain competitive margins. Understanding the cumulative impact of these trade policies is essential for executives to navigate procurement strategies, optimize distribution networks, and preserve continuity of care.

Nuanced Market Insights Across Key Segmentation Dimensions

A granular view of market segmentation reveals distinct growth drivers and adoption barriers across multiple dimensions. Based on disease type, oncology channels for breast, colorectal, and lung cancer command significant investment in innovative therapeutics and monitoring platforms, while cardiovascular subsegments such as coronary artery disease, heart failure, and hypertension leverage remote monitoring to reduce readmissions. Diabetes management spans gestational, Type 1, and Type 2 care pathways with continuous glucose monitors and insulin pumps forging deeper patient adherence.

Considering product type, device innovations-from implantable defibrillators and pacemakers to nebulizers-are complemented by analytics platforms and clinical management software that synthesize patient data into actionable insights. Biologics, prescription medications, and over-the-counter drugs address therapeutic needs, enhancing chronic care efficacy. When viewed through the lens of service type, home health settings and telehealth offerings are rapidly expanding at the expense of traditional inpatient modalities, reflecting patient preference for convenience and continuity.

End users such as clinics, hospitals, diagnostic centers, and home health providers are increasingly interoperable, delivering care that bridges physical and digital channels. Meanwhile, specialty and online pharmacies complement hospital and retail outlets to improve access. Finally, differing care settings-from inpatient wards to ambulatory and day-care environments-underscore the importance of flexible delivery models to optimize resource utilization and patient experience.

Divergent Regional Landscapes Influencing Market Dynamics

Regional markets display distinct trajectories shaped by demographic, regulatory, and economic factors. In the Americas, sustained investments in health care infrastructure and a robust pipeline of digital health startups drive rapid adoption of remote monitoring solutions and telehealth platforms. North American payers and government agencies are collaborating on value-based initiatives that align incentives for preventive care and chronic disease control.

Within Europe, Middle East & Africa, regulatory harmonization under broader trade agreements is facilitating cross-border clinical trials and market entry for novel therapeutics. National health systems in Western Europe emphasize cost containment through centralized procurement, while emerging economies in the Middle East and Africa pursue public-private partnerships to bridge care gaps and support decentralized care models.

Asia-Pacific presents a diverse mix of high-growth economies investing heavily in health care digitization and domestic manufacturing. Governments across the region are launching e-health frameworks and telemedicine licensure reforms to expand rural access. As these markets mature, localized partnerships and technology transfers are accelerating the commercialization of chronic disease management solutions tailored to regional epidemiology and resource constraints.

Strategic Movements Among Market Leaders

Leading organizations are harnessing mergers, strategic alliances, and technology acquisitions to consolidate their presence across the chronic care continuum. Device manufacturers are integrating software capabilities through targeted acquisitions of analytics and patient engagement platform developers, strengthening their end-to-end solution portfolios. Pharmaceutical companies are forging co-development agreements with biotechnology firms to expand biologics pipelines focused on oncology and autoimmune disorders.

Service providers are collaborating with telehealth startups and home health agencies to deliver hybrid care models that blend virtual check-ins with in-home diagnostics. Diagnostic center networks are forging exclusive distribution partnerships with specialty pharmacies, ensuring streamlined therapy access and adherence support. Collectively, these company-level initiatives reflect a concerted effort to build integrated ecosystems that address the entire patient journey from screening and diagnosis to long-term monitoring and intervention.

Actionable Strategies to Elevate Chronic Disease Outcomes

Industry leaders should prioritize strategic investments in digital monitoring infrastructure and predictive analytics to preempt disease exacerbations and reduce hospital readmissions. Diversifying supply chains and exploring localized manufacturing partnerships can mitigate tariff-related cost pressures while ensuring consistent access to critical devices and therapeutics. Embracing hybrid care delivery by integrating telehealth with home-based services will meet evolving patient preferences and optimize resource allocation.

Executives must also focus on forging cross-sector alliances that leverage complementary strengths in technology, distribution, and clinical expertise. Tailoring product portfolios and service offerings to regional epidemiology and regulatory environments will unlock new growth corridors. Finally, upskilling the health care workforce to navigate digital platforms and data-driven workflows is essential for sustaining quality care delivery and operational efficiency in an increasingly complex chronic disease landscape.

Rigorous Mixed-Methodology Underpinning the Analysis

This analysis draws upon a robust mixed-methodology framework combining primary engagements with senior stakeholders-ranging from health system executives to technology innovators-with comprehensive secondary research across peer-reviewed journals, regulatory filings, and market intelligence databases. Qualitative insights were validated through expert panel reviews to ensure interpretive rigor, while quantitative data were cross-checked against multiple reputable sources to confirm consistency.

A multi-tiered approach to data triangulation underpins all findings, incorporating scenario analyses and sensitivity tests to identify critical uncertainties. Methodological transparency and adherence to industry best practices provide stakeholders with confidence in the reliability of conclusions. Ethical standards and data governance protocols were maintained throughout, safeguarding the integrity and confidentiality of all proprietary information gathered.

Critical Takeaways for Stakeholder Engagement

Bringing together detailed segmentation insights, regional evaluations, tariff impact assessments, and competitive intelligence, this executive summary equips stakeholders with a nuanced understanding of the chronic disease management market. The synthesis of technological, regulatory, and economic drivers informs a strategic roadmap for navigating emerging challenges and capitalizing on growth opportunities.

As the industry pivots toward patient-centric, data-enabled care models, organizations that adopt proactive, collaborative, and agile approaches will be best positioned to improve clinical outcomes while containing costs. This conclusion underscores the imperative for continuous innovation, cross-sector partnerships, and targeted investments in capabilities that align with evolving market dynamics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Disease Type
    • Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Lung Cancer
    • Cardiovascular Disease
      • Coronary Artery Disease
      • Heart Failure
      • Hypertension
    • Diabetes
      • Gestational Diabetes
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Respiratory Disease
      • Asthma
      • Copd
  • Product Type
    • Devices
      • Delivery Devices
        • Insulin Pumps
        • Nebulizers
      • Implantable Devices
        • Implantable Defibrillators
        • Pacemakers
      • Monitoring Devices
        • Continuous Glucose Monitors
        • Ecg Monitors
        • Pulse Oximeters
    • Software
      • Analytics Platforms
      • Clinical Management Software
      • Patient Engagement Tools
    • Therapeutics
      • Biologics
      • Otc Drugs
      • Prescription Drugs
  • Service Type
    • Home Healthcare
    • Hospital
    • Outpatient Clinic
    • Telehealth
  • End User
    • Clinics
    • Diagnostic Centers
    • Home Healthcare Providers
    • Hospitals
    • Patients
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
    • Specialty Pharmacy
  • Care Setting
    • Homecare
    • Inpatient
    • Outpatient
      • Ambulatory Care
      • Day Care
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Roche Holding AG
  • Dexcom, Inc.
  • ResMed Inc.
  • Allscripts Healthcare Solutions, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Chronic Disease Management Market, by Disease Type
8.1. Introduction
8.2. Cancer
8.2.1. Breast Cancer
8.2.2. Colorectal Cancer
8.2.3. Lung Cancer
8.3. Cardiovascular Disease
8.3.1. Coronary Artery Disease
8.3.2. Heart Failure
8.3.3. Hypertension
8.4. Diabetes
8.4.1. Gestational Diabetes
8.4.2. Type 1 Diabetes
8.4.3. Type 2 Diabetes
8.5. Respiratory Disease
8.5.1. Asthma
8.5.2. Copd
9. Chronic Disease Management Market, by Product Type
9.1. Introduction
9.2. Devices
9.2.1. Delivery Devices
9.2.1.1. Insulin Pumps
9.2.1.2. Nebulizers
9.2.2. Implantable Devices
9.2.2.1. Implantable Defibrillators
9.2.2.2. Pacemakers
9.2.3. Monitoring Devices
9.2.3.1. Continuous Glucose Monitors
9.2.3.2. Ecg Monitors
9.2.3.3. Pulse Oximeters
9.3. Software
9.3.1. Analytics Platforms
9.3.2. Clinical Management Software
9.3.3. Patient Engagement Tools
9.4. Therapeutics
9.4.1. Biologics
9.4.2. Otc Drugs
9.4.3. Prescription Drugs
10. Chronic Disease Management Market, by Service Type
10.1. Introduction
10.2. Home Healthcare
10.3. Hospital
10.4. Outpatient Clinic
10.5. Telehealth
11. Chronic Disease Management Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Diagnostic Centers
11.4. Home Healthcare Providers
11.5. Hospitals
11.6. Patients
12. Chronic Disease Management Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
12.5. Specialty Pharmacy
13. Chronic Disease Management Market, by Care Setting
13.1. Introduction
13.2. Homecare
13.3. Inpatient
13.4. Outpatient
13.4.1. Ambulatory Care
13.4.2. Day Care
14. Americas Chronic Disease Management Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Chronic Disease Management Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Chronic Disease Management Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Koninklijke Philips N.V.
17.3.2. GE HealthCare Technologies Inc.
17.3.3. Siemens Healthineers AG
17.3.4. Medtronic plc
17.3.5. Johnson & Johnson
17.3.6. Abbott Laboratories
17.3.7. Roche Holding AG
17.3.8. Dexcom, Inc.
17.3.9. ResMed Inc.
17.3.10. Allscripts Healthcare Solutions, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CHRONIC DISEASE MANAGEMENT MARKET MULTI-CURRENCY
FIGURE 2. CHRONIC DISEASE MANAGEMENT MARKET MULTI-LANGUAGE
FIGURE 3. CHRONIC DISEASE MANAGEMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CHRONIC DISEASE MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CHRONIC DISEASE MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CHRONIC DISEASE MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COPD, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ECG MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PULSE OXIMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ANALYTICS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLINICAL MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PATIENT ENGAGEMENT TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OTC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOME HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DAY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 111. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 113. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 114. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 115. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 116. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 119. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 120. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 121. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 122. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 123. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 127. CANADA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 128. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 130. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 137. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 138. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 140. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 144. MEXICO CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 214. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 215. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 216. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 218. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 219. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 221. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 222. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 224. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 225. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 226. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 227. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 230. GERMANY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 231. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 233. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 234. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 235. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 236. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 238. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 239. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 240. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 241. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 242. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 243. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 244. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 247. FRANCE CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 265. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 266. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 267. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 268. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 269. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 270. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 272. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 273. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 274. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 275. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 276. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 277. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 278. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 281. ITALY CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 282. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 283. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 285. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 289. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 291. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 292. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 293. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 294. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 295. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 298. SPAIN CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY OUTPATIENT, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DIABETES, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY RESPIRATORY DISEASE, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DELIVERY DEVICES, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CHRONIC DISEASE MANAGEMENT MARKET SIZE, BY CARE SETTING, 2018-2030 (USD MILLION)
TABLE 315.

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Chronic Disease Management market report include:
  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Roche Holding AG
  • Dexcom, Inc.
  • ResMed Inc.
  • Allscripts Healthcare Solutions, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 10.85 Billion
Forecasted Market Value ( USD ) by 2030 $ 15.1 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Disease Management Apps Market by Platform, Indication, Revenue Model, End-User - Global Forecast to 2030 - Product Image

Disease Management Apps Market by Platform, Indication, Revenue Model, End-User - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Chronic Disease Management - Global Stategic Business Report - Product Image

Chronic Disease Management - Global Stategic Business Report

  • Report
  • 488 Pages
  • Global
From
Disease Management Apps - Global Strategic Business Report - Product Image

Disease Management Apps - Global Strategic Business Report

  • Report
  • 232 Pages
  • Global
From
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets - Product Image

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

  • Report
  • 157 Pages
  • Global
From
Chronic Disease Management Market Report 2025 - Product Image

Chronic Disease Management Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.